With Phase 3 data showing what analysts called a “potentially best-in-class profile,” Arrowhead Pharmaceuticals plans to submit for FDA approval of plozasiran by the end of the year—hoping to follow to market Ionis Pharmaceuticals’ Tryngolza, which got the regulator’s nod in severe hypertriglyceridemia last month.
Arrowhead puts pressure on Ionis with positive data for triglyceride lowering drug Read More »
The company agreed to buy a diabetes health business and medical supplier Strive Medical to boost its growing in-home solutions unit.
Cardinal inks 2 acquisitions in bid to expand at-home services Read More »
Looking for a biopharma job in Cambridge? Roles posted on BioSpace have more than doubled compared to last year.
A Congressional advisory panel recommends the U.S. government put supportive policies in place for rare disease drug development, such as a finalized platform designation from the FDA and the allowance of novel trial designs for small patient populations.
US ‘eroding’ lead in rare diseases a matter of national security: Report Read More »
Second quarter earnings continue to roll with Novartis and Roche reporting this week; Eli Lilly’s AtaiBeckley buy for up to $3.8 billion offers clear “validation” for the fledgling psychedelics space; more drama unfolds at FDA as the agency goes back and forth on its policy of publishing complete response letters in real-time; and IPO fever
Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2 Read More »
The discontinued asset, being trialed for breast cancer and solid tumors, had yielded disappointing data, leading to Novartis’ decision to abandon development, according to a company spokesperson.
Novartis scraps mid-stage radiopharma asset as Pluvicto soars Read More »
La búsqueda de eficiencia en la arquitectura actual está transformando incluso los sistemas de climatización de las viviendas. Y, entre las tecnologías disponibles en el mercado, la instalación de suelo radiante con aerotermia destaca como una de las opciones m&aac …
Estamos a finales del siglo XIX. Un paciente sufre una hemorragia masiva y los médicos, en un intento desesperado por salvarlo, deciden transferirle sangre de un donante sano. En ocasiones, el paciente se recuperaba de forma milagrosa; en muchas otras, sufría dolores espantosos, orinab …
Karl Landsteiner, el hombre que descifró la sangre Read More »
Durante siglos se nos ha enseñado una narrativa simple: Galileo Galilei inventó el telescopio en 1609, miró al cielo y transformó la astronomía para siempre. Sin embargo, la historia de la ciencia rara vez es tan lineal. Si rascamos la superficie del tiempo, descub …
Pasamos aproximadamente un tercio de nuestra vida con los ojos cerrados, sumergidos en un estado de aparente vulnerabilidad. Durante décadas, la ciencia consideró el sueño como un simple interruptor biológico: un estado pasivo donde el cuerpo descansaba y la mente se apag …
¿Qué pasa en tu cerebro durante el sueño profundo y por qué morirías si no duermes? Read More »
